Health Populi
MAY 26, 2021
The emergence of the COVID-19 vaccine “infodemic” has slowed the ability for nations around the world to emerge out of the public health crisis. Growing cynicism among some health citizens facing the politicization of public health tactics like vaccines and facial masks is what we’re talking about.
Health Populi
MAY 20, 2021
You’re stressed, I’m stressed; most of us have felt stress in the COVID-19 era which began in the U.S. in the first quarter of 2020. Nearly eighteen months later, a 2021 Edelman Trust Barometer update finds that consumers’ trust in the health care industry is under stress, too — in the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
APRIL 27, 2021
In April 2020, the U.S. Centers for Disease Control issued a report featuring evidence that in the month of March 2020, the coronavirus pandemic was not an equal-opportunity killer. ASPE analyzed data from 62,451,150 people who had 1 or more vaccine doses administered by 3-10-21. of Hispanic and LatinX people (19% of U.S.
Health Populi
JUNE 8, 2021
In the COVID-19 pandemic, health care spending in the U.S. This year, medical cost trend will rise by 7.0%, expected to decline a bit in 2022 according to the annual study from PwC Health Research Institute , Medical Cost Trend: Behind the Numbers 2022. increased by a relatively low 6.0%
Bill of Health
NOVEMBER 9, 2023
Despite the important enactment in 2010 of the Patient Protection and Affordable Care Act (ACA), which increases access to care by expanding Medicaid eligibility and protecting insurance coverage of people with pre-existing health conditions and disabilities, more than 25 million people remain uninsured.
Health Populi
MAY 4, 2023
” I’ve pulled out a few of the data points that speak to me about population health, prevention and early diagnosis (or lack thereof), and alarm bells on women’s health — notably, young women and girls.
Health Populi
JUNE 24, 2021
On the pharma supply side, mRNA vaccines will dominate the market, proving more effective than others at stemming a further outbreak. With growing global supply and competition, we can expect prices for COVID-19 vaccines to fall, anticipating additional volumes from Sinopharm, Moderna, Sinovac, Gamaleya Institute, among others.
Expert insights. Personalized for you.
87 
Let's personalize your content